Rezolute RZLT Stock
Rezolute Price Chart
Rezolute RZLT Financial and Trading Overview
| Rezolute stock price | 3.82 USD |
| Previous Close | 1.98 USD |
| Open | 2.02 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 1.96 - 2.05 USD |
| 52 Week Range | 1.34 - 3.59 USD |
| Volume | 7.73K USD |
| Avg. Volume | 33.25K USD |
| Market Cap | 75.5M USD |
| Beta (5Y Monthly) | 2.184507 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.23 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.8 USD |
RZLT Valuation Measures
| Enterprise Value | -27769418 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.423611 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.5929997 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.524 |
Trading Information
Rezolute Stock Price History
| Beta (5Y Monthly) | 2.184507 |
| 52-Week Change | -37.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.59 USD |
| 52 Week Low | 1.34 USD |
| 50-Day Moving Average | 2.05 USD |
| 200-Day Moving Average | 2.12 USD |
RZLT Share Statistics
| Avg. Volume (3 month) | 33.25K USD |
| Avg. Daily Volume (10-Days) | 8.51K USD |
| Shares Outstanding | 36.83M |
| Float | 25.78M |
| Short Ratio | 10.76 |
| % Held by Insiders | 16.65% |
| % Held by Institutions | 68.01% |
| Shares Short | 151.27K |
| Short % of Float | 0.64% |
| Short % of Shares Outstanding | 0.41% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.54% |
| Return on Equity (ttm) | -54.10% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -53027000 USD |
| Net Income Avi to Common (ttm) | -48482000 USD |
| Diluted EPS (ttm) | -0.76 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 103.06M USD |
| Total Cash Per Share (mrq) | 2.8 USD |
| Total Debt (mrq) | 2.37M USD |
| Total Debt/Equity (mrq) | 1.87 USD |
| Current Ratio (mrq) | 24.054 |
| Book Value Per Share (mrq) | 3.457 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -45241000 USD |
| Levered Free Cash Flow (ttm) | -27282624 USD |
Profile of Rezolute
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 201 Redwood Shores Parkway |
| ZIP | 94065 |
| Phone | 650 206 4507 |
| Website | https://www.rezolutebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 47 |
Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
Q&A For Rezolute Stock
What is a current RZLT stock price?
Rezolute RZLT stock price today per share is 3.82 USD.
How to purchase Rezolute stock?
You can buy RZLT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rezolute?
The stock symbol or ticker of Rezolute is RZLT.
Which industry does the Rezolute company belong to?
The Rezolute industry is Biotechnology.
How many shares does Rezolute have in circulation?
The max supply of Rezolute shares is 85.48M.
What is Rezolute Price to Earnings Ratio (PE Ratio)?
Rezolute PE Ratio is now.
What was Rezolute earnings per share over the trailing 12 months (TTM)?
Rezolute EPS is -1.23 USD over the trailing 12 months.
Which sector does the Rezolute company belong to?
The Rezolute sector is Healthcare.
Rezolute RZLT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17485.33 USD — |
+0.69
|
10.87B USD — | 17256.2 USD — | 17500.41 USD — | — - | 10.87B USD — |
| NASDAQ HealthCare IXHC | 935.38 USD — |
+0.47
|
— — | 922.07 USD — | 938.83 USD — | — - | — — |
- {{ link.label }} {{link}}